Inventor · disambiguated record
Alexander Sokolsky
Also filed as: SOKOLSKY ALEXANDER
35 granted patents·16 pending applications·396 citations·filing 2016–2025
97Inventor score
Files withINCYTE CORP51
Top patents by PatentIndex Score
51 records- 0198US11173162B2Bicyclic heterocycles as FGFR4 inhibitorsINCYTE CORP·Filed 2020·Granted Nov 16, 2021·22 cites·19 claims
- 0298US10632126B2Bicyclic heterocycles as FGFR4 inhibitorsINCYTE CORP·Filed 2019·Granted Apr 28, 2020·27 cites·8 claims
- 0397US11542265B2Pyrazolopyrimidine compounds and uses thereofINCYTE CORP·Filed 2021·Granted Jan 3, 2023·8 cites·43 claims
- 0497US11492354B2Indazole compounds and uses thereofINCYTE CORP·Filed 2020·Granted Nov 8, 2022·8 cites·71 claims
- 0597US11242343B2Pyrazolopyridine compounds and uses thereofINCYTE CORP·Filed 2020·Granted Feb 8, 2022·12 cites·27 claims
- 0697US10934288B2Pyrazolopyridine compounds and uses thereofINCYTE CORP·Filed 2019·Granted Mar 2, 2021·13 cites·8 claims
- 0797US10745388B2Indazole compounds and uses thereofINCYTE CORP·Filed 2019·Granted Aug 18, 2020·24 cites·22 claims
- 0897US10435405B2Pyrazolopyridine compounds and uses thereofINCYTE CORP·Filed 2018·Granted Oct 8, 2019·23 cites·16 claims
- 0997US10251892B2Bicyclic heterocycles as FGFR4 inhibitorsINCYTE CORP·Filed 2017·Granted Apr 9, 2019·33 cites·1 claims
- 1097US9708318B2Bicyclic heterocycles as FGFR4 inhibitorsINCYTE CORP·Filed 2016·Granted Jul 18, 2017·44 cites·41 claims
- 1196US11066404B2Dihydropyrido[2,3-d]pyrimidinone compounds as CDK2 inhibitorsINCYTE CORP·Filed 2019·Granted Jul 20, 2021·13 cites·24 claims
- 1296US10752635B2Indazole compounds and uses thereofINCYTE CORP·Filed 2019·Granted Aug 25, 2020·16 cites·67 claims
- 1396US10266530B2Pyrazolopyridine compounds and uses thereofINCYTE CORP·Filed 2017·Granted Apr 23, 2019·24 cites·42 claims
- 1495US11891388B2Pyrazolopyridine compounds and uses thereofINCYTE CORP·Filed 2021·Granted Feb 6, 2024·3 cites·30 claims
- 1595US11866432B2Dihydropyrido[2,3-d]pyrimidinone compounds as CDK2 inhibitorsINCYTE CORP·Filed 2021·Granted Jan 9, 2024·3 cites·34 claims
- 1695US11731958B2Carboxamide compounds and uses thereofINCYTE CORP·Filed 2020·Granted Aug 22, 2023·4 cites·25 claims
- 1795US11406624B2Pyrazolopyridine compounds and uses thereofINCYTE CORP·Filed 2019·Granted Aug 9, 2022·9 cites·16 claims
- 1895US11384083B2Substituted spiro[cyclopropane-1,5′-pyrrolo[2,3-d]pyrimidin]-6′(7′h)-ones as CDK2 inhibitorsINCYTE CORP·Filed 2020·Granted Jul 12, 2022·6 cites·19 claims
- 1995US10899755B2Benzothiazole compounds and uses thereofINCYTE CORP·Filed 2019·Granted Jan 26, 2021·15 cites·39 claims
- 2095US10800761B2Carboxamide compounds and uses thereofINCYTE CORP·Filed 2019·Granted Oct 13, 2020·15 cites·12 claims
- 2194US11866426B2Benzothiazole compounds and uses thereofINCYTE CORP·Filed 2020·Granted Jan 9, 2024·3 cites·41 claims
- 2294US10280164B2Pyrazolopyridone compounds and uses thereofINCYTE CORP·Filed 2017·Granted May 7, 2019·24 cites·38 claims
- 2393US12384778B2Pyrazolopyridine compounds and uses thereofINCYTE CORP·Filed 2023·Granted Aug 12, 2025·1 cites·49 claims
- 2493US11795166B2Pyrazolopyridine compounds and uses thereofINCYTE CORP·Filed 2021·Granted Oct 24, 2023·2 cites·26 claims
- 2593US9920032B2Heterocyclic compounds useful as pim kinase inhibitorsINCYTE CORP·Filed 2016·Granted Mar 20, 2018·12 cites·31 claims
- 2692US11299473B2Benzimidazole and indole compounds and uses thereofINCYTE CORP·Filed 2019·Granted Apr 12, 2022·10 cites·56 claims
- 2792US11014929B2Pyrazolopyrimidine compounds and uses thereofINCYTE CORP·Filed 2019·Granted May 25, 2021·12 cites·54 claims
- 2891US11919904B2Sulfonylamide compounds as CDK2 inhibitorsINCYTE CORP·Filed 2020·Granted Mar 5, 2024·3 cites·41 claims
- 2988US10450296B2Heterocyclic compounds useful as Pim kinase inhibitorsINCYTE CORP·Filed 2018·Granted Oct 22, 2019·6 cites·25 claims
- 3080US11939328B2Quinoline compounds as inhibitors of KRASINCYTE CORP·Filed 2022·Granted Mar 26, 2024·0 cites·35 claims
- 3180US11053215B2Heterocyclic compounds useful as Pim kinase inhibitorsINCYTE CORP·Filed 2019·Granted Jul 6, 2021·1 cites·12 claims
- 3279US12378243B2Quinoline compounds as inhibitors of KRASINCYTE CORP·Filed 2024·Granted Aug 5, 2025·0 cites·34 claims
- 3377US12466815B2Carboxamide compounds and uses thereofINCYTE CORP·Filed 2023·Granted Nov 11, 2025·0 cites·66 claims
- 3474US2025368641A1Quinoline compounds as inhibitors of krasINCYTE CORP·Filed 2025·Application pending·0 cites
- 3572US2024343742A1Vinyl imidazole compounds as inhibitors of krasINCYTE CORP·Filed 2024·Application pending·0 cites
- 3669US2025188073A1Tricyclic compounds as inhibitors of krasINCYTE CORP·Filed 2024·Application pending·0 cites
- 3768US2025163079A1Kras inhibitorsINCYTE CORP·Filed 2024·Application pending·0 cites
- 3865US2019315743A1Pyrazolopyridine compounds and uses thereofINCYTE CORP·Filed 2019·Application pending·0 cites
- 3964US2024368156A12-azabicyclo[2.2.1]heptane kras inhibitorsINCYTE CORP·Filed 2024·Application pending·0 cites
- 4063US2025195536A1Bicyclooctane kras inhibitorsINCYTE CORP·Filed 2024·Application pending·0 cites
- 4162US2024358702A1Cyclic urea kras inhibitorsINCYTE CORP·Filed 2024·Application pending·0 cites
- 4261US11999752B2Vinyl imidazole compounds as inhibitors of KRASINCYTE CORP·Filed 2021·Granted Jun 4, 2024·0 cites·38 claims
- 4360US2024390340A1Pyrrolidine kras inhibitorsINCYTE CORP·Filed 2024·Application pending·0 cites
- 4460US2024101557A1Fused tricyclic compounds as inhibitors of kras g12v mutantsINCYTE CORP·Filed 2023·Application pending·0 cites
- 4560US2018072718A1Pyrazolopyridine compounds and uses thereofINCYTE CORP·Filed 2017·Application pending·0 cites
- 4658US2021269434A1Tricyclic compounds as inhibitors of krasINCYTE CORP·Filed 2021·Application pending·0 cites
- 4757US2023226040A1Combination therapy comprising an fgfr inhibitor and a kras inhibitorINCYTE CORP·Filed 2022·Application pending·0 cites
- 4855US12331063B2Hetero-bicyclic inhibitors of KRASINCYTE CORP·Filed 2022·Granted Jun 17, 2025·0 cites·36 claims
- 4953US2018072741A1Pyrazolopyrimidine compounds and uses thereofINCYTE CORP·Filed 2017·Application pending·0 cites
- 5049US2018228786A1Pyrazolopyridine compounds and uses thereofINCYTE CORP·Filed 2018·Application pending·0 cites
Showing the top 50 of 51 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Alexander Sokolsky files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →